Yervoy 50mg Injection (Ipilimumab) – Complete Product Description

Yervoy 50mg Injection (Ipilimumab) is a prescription immunotherapy medicine manufactured by Bristol Myers Squibb (BMS). It contains ipilimumab, a recombinant human monoclonal antibody that belongs to a class of medicines known as immune checkpoint inhibitors.

Yervoy works by targeting CTLA-4 (cytotoxic T-lymphocyte-associated antigen 4), a protein involved in regulating the immune response. By blocking CTLA-4, ipilimumab can enhance T-cell activity and help the body’s immune system recognize and attack certain cancer cells.

Yervoy is used for selected patients with certain cancers and may be prescribed alone or in combination with other cancer medicines, depending on the specific diagnosis and approved treatment regimen.

The product listed here is Yervoy 50mg Injection, manufactured by Bristol Myers Squibb, with a pack size of 1 injection/vial. It is administered by intravenous infusion under the supervision of a qualified healthcare professional.

Yervoy 50mg Injection – Product Information

Brand Name: Yervoy
Active Ingredient: Ipilimumab
Strength: 50mg
Presentation: 50mg/10mL
Dosage Form: Concentrate for solution for intravenous infusion
Route of Administration: Intravenous (IV) infusion
Manufacturer: Bristol Myers Squibb
Pack Size: 1 injection/vial
Drug Class: Immune checkpoint inhibitor
Therapeutic Class: Cancer immunotherapy / Antineoplastic medicine
Target: CTLA-4
Prescription Status: Prescription medicine

Yervoy is a specialized biological cancer medicine and should only be prepared and administered by appropriately trained healthcare professionals.

What Is Yervoy 50mg Injection Used For?

Yervoy (Ipilimumab) is used in selected cancer treatment regimens. Depending on the patient’s cancer type and applicable approved indication, ipilimumab may be used for:

• Unresectable or metastatic melanoma
• Adjuvant treatment of certain melanoma patients
• Advanced renal cell carcinoma
• Certain metastatic colorectal cancers with appropriate biomarkers
• Hepatocellular carcinoma
• Non-small cell lung cancer
• Malignant pleural mesothelioma
• Esophageal cancer
• Other approved cancer indications in specific combination regimens

The exact indication depends on the cancer type, stage, biomarker status, previous treatment and the applicable treatment protocol.

Yervoy for Melanoma

Yervoy was developed as an important immunotherapy for advanced melanoma.

Ipilimumab can be used as monotherapy in selected patients or in combination with other immune checkpoint inhibitors, particularly nivolumab, depending on the patient’s clinical situation.

By blocking CTLA-4, Yervoy can enhance T-cell activation and help the immune system recognize cancer cells.

Yervoy for Renal Cell Carcinoma

Ipilimumab may be used in combination with nivolumab for selected patients with advanced renal cell carcinoma.

The combination provides complementary immune checkpoint blockade by targeting different regulatory pathways involved in T-cell activity.

Yervoy for Colorectal Cancer

Yervoy may be used in combination with nivolumab for certain patients with metastatic colorectal cancer whose tumors have specific molecular characteristics, such as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) disease, according to the applicable indication.

Yervoy for Lung Cancer

Ipilimumab may be used in combination with other immunotherapy and/or chemotherapy in selected patients with advanced non-small cell lung cancer (NSCLC).

The appropriate regimen depends on the patient’s disease characteristics and treatment history.

Yervoy for Hepatocellular Carcinoma

Yervoy can be used in selected treatment combinations for certain patients with advanced hepatocellular carcinoma (HCC).

The treating oncologist determines whether an ipilimumab-containing regimen is appropriate.

How Does Yervoy (Ipilimumab) Work?

Yervoy contains ipilimumab, a monoclonal antibody that targets CTLA-4.

CTLA-4 is an immune checkpoint protein that helps regulate T-cell activity. Cancer cells can take advantage of natural immune-regulatory mechanisms to avoid effective immune attack.

Ipilimumab blocks CTLA-4 and removes one of the inhibitory signals that can limit T-cell activation.

This can enhance the body’s immune response against cancer cells.

Unlike traditional chemotherapy, Yervoy does not directly destroy cancer cells through cytotoxic chemical action. Instead, it activates and enhances the immune system’s ability to fight cancer.

Yervoy 50mg Dose and Administration

Yervoy 50mg is administered by intravenous infusion.

The exact dosage and treatment schedule depend on the cancer being treated and whether Yervoy is used alone or in combination with other medicines.

Ipilimumab may be administered at different doses and intervals for different indications. For example, certain melanoma regimens use 3mg/kg, while some combination treatment protocols use 1mg/kg.

Therefore, the 50mg vial should not be interpreted as the patient’s complete treatment dose. The treating oncologist calculates the required dose according to the patient’s treatment regimen and body weight.

Yervoy should generally be administered as an intravenous infusion over an appropriate period according to the prescribing information.

Do not self-inject Yervoy.

Treatment should take place in a medical facility capable of recognizing and managing immune-related adverse reactions.

Common Side Effects of Yervoy 50mg

Because Yervoy activates the immune system, its side effects can differ from those associated with traditional chemotherapy.

Commonly reported adverse effects may include:

• Fatigue
• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Reduced appetite
• Rash
• Itching
• Headache
• Fever
• Cough
• Joint pain
• Muscle pain
• Weakness

The frequency and severity of side effects can increase when Yervoy is used in combination with other immunotherapy medicines.

Serious Immune-Related Side Effects

One of the most important characteristics of Yervoy is that it can cause the immune system to attack normal organs and tissues.

These reactions can be serious or potentially life-threatening and may require corticosteroids or other immunosuppressive treatment.

Immune-Mediated Colitis

Yervoy can cause inflammation of the colon.

Symptoms may include:

• Persistent diarrhea
• Abdominal pain
• Blood or mucus in stools
• Fever

Severe diarrhea should be reported promptly to the treating physician.

Immune-Mediated Hepatitis

Yervoy can cause inflammation of the liver.

Possible symptoms include:

• Yellowing of the skin or eyes
• Dark urine
• Abdominal pain
• Unusual fatigue
• Loss of appetite

Liver function tests are generally monitored during treatment.

Immune-Mediated Pneumonitis

Inflammation of the lungs can occur with immune checkpoint inhibitors.

Patients should report:

• New or worsening cough
• Shortness of breath
• Chest discomfort
• Difficulty breathing

Immune-Mediated Endocrine Disorders

Yervoy may affect hormone-producing glands, including the:

• Pituitary gland
• Thyroid gland
• Adrenal glands

Possible symptoms include persistent fatigue, headache, dizziness, changes in weight, unusual thirst or changes in mood.

Hormone levels may be monitored during treatment.

Immune-Mediated Nephritis

Inflammation of the kidneys can occur rarely.

Your healthcare provider may monitor kidney function during treatment.

Skin Reactions

Yervoy can cause immune-related skin reactions, including rash and itching.

Severe skin reactions require urgent medical evaluation.

Precautions Before Using Yervoy 50mg

Before receiving Yervoy, tell your doctor if you have:

• An autoimmune disease
• A history of organ transplantation
• Liver disease
• Lung disease
• Colitis or inflammatory bowel disease
• Thyroid or other endocrine disorders
• Previous severe immune-related reactions
• A history of serious allergies to monoclonal antibodies

Inform your healthcare provider about all prescription medicines, over-the-counter medicines, supplements and other cancer treatments.

Yervoy and Laboratory Monitoring

Because ipilimumab can cause immune-related complications, healthcare professionals may regularly monitor:

• Liver function
• Kidney function
• Thyroid function
• Other hormone levels
• Blood counts
• Symptoms associated with immune-related toxicity

Regular monitoring allows potential complications to be detected and treated as early as possible.

Yervoy During Pregnancy

Yervoy may cause fetal harm when administered during pregnancy because immune checkpoint inhibition can affect pregnancy and fetal development.

Women who can become pregnant should discuss effective contraception with their healthcare provider before starting treatment and during the recommended period after the final dose.

If pregnancy occurs while receiving Yervoy, inform the treating healthcare professional promptly.

Yervoy and Breastfeeding

It is not known with certainty whether ipilimumab passes into human breast milk.

Because of the potential for serious adverse reactions in a breastfed infant, patients should discuss breastfeeding with their oncologist before starting treatment.

Your healthcare provider will advise whether breastfeeding should be discontinued during treatment and for the appropriate period afterward.

Yervoy 50mg Storage

Yervoy is a biological medicine requiring controlled storage and handling.

The unopened vial should be stored according to the manufacturer’s approved storage conditions and protected from light.

Do not freeze or shake Yervoy.

The medicine must be diluted and prepared using appropriate sterile procedures before intravenous administration.

Prepared Yervoy solution should be handled according to approved pharmaceutical procedures.

Yervoy 50mg Injection Price in Pakistan

The Yervoy 50mg Injection price in Pakistan may vary depending on availability, supplier, import costs, exchange rates and prevailing market conditions.

For the latest Yervoy 50mg price in Pakistan, customers can contact MedicineWalyDost.com to check current availability and pricing.

Because Yervoy is a specialized oncology biological medicine, prices may vary considerably. Customers should confirm the latest price before placing an order.

Why Choose Yervoy 50mg Injection?

Yervoy contains ipilimumab, a pioneering immune checkpoint inhibitor that targets CTLA-4 and enhances T-cell activity against cancer.

It has an important role in modern cancer immunotherapy and may be used alone or in combination with other immunotherapy or anticancer medicines for selected patients.

The Bristol Myers Squibb Yervoy 50mg Injection presentation is supplied in a pack size of 1 injection/vial and is intended for intravenous infusion under professional medical supervision.

Frequently Asked Questions About Yervoy 50mg

What is Yervoy 50mg Injection?

Yervoy 50mg Injection is a prescription immunotherapy medicine containing ipilimumab, a monoclonal antibody that blocks the CTLA-4 immune checkpoint.

What is the generic name of Yervoy?

The generic name is ipilimumab.

Who manufactures Yervoy 50mg Injection?

The manufacturer of the product listed here is Bristol Myers Squibb (BMS).

What is the pack size of Yervoy 50mg?

The pack size is 1 injection/vial.

How is Yervoy 50mg administered?

Yervoy is administered by intravenous infusion by a qualified healthcare professional.

What is Yervoy used for?

Yervoy is used in selected treatment regimens for cancers including melanoma, renal cell carcinoma, colorectal cancer with specific biomarkers, hepatocellular carcinoma and certain lung and other cancers.

Is Yervoy chemotherapy?

No. Yervoy is an immunotherapy and immune checkpoint inhibitor, not conventional chemotherapy. It works by enhancing T-cell activity against cancer cells.

Can Yervoy be used with Opdivo?

Yes. Ipilimumab is used in combination with nivolumab (Opdivo) in several approved treatment regimens. The exact combination, dose and schedule depend on the cancer being treated.

What are the most important risks of Yervoy?

Yervoy can cause serious immune-mediated adverse reactions, including inflammation of the colon, liver, lungs, kidneys and endocrine glands. Prompt medical evaluation is important if new or worsening symptoms develop.

Does Yervoy require medical supervision?

Yes. Yervoy is a prescription oncology immunotherapy and should be administered in an appropriate medical setting by qualified healthcare professionals.

Can Yervoy 50mg be purchased without a prescription?

Yervoy is a specialized prescription cancer medicine and should only be used under the supervision of a qualified oncologist.

Order Yervoy 50mg Injection in Pakistan

Looking for Yervoy 50mg Injection (Ipilimumab) by Bristol Myers Squibb in Pakistan?

MedicineWalyDost.com provides access to specialized prescription medicines and oncology products. Contact us to check the latest Yervoy 50mg price, availability and ordering information.

Before ordering, confirm the brand, strength, active ingredient, manufacturer, pack size and prescription requirements with your doctor or pharmacist.

Order Yervoy 50mg Injection from MedicineWalyDost.com and contact us today for current availability and pricing.

Important Medical Disclaimer

Yervoy 50mg Injection is a prescription cancer immunotherapy. This product description is provided for educational and e-commerce purposes only and does not replace professional medical advice. Yervoy can cause serious or life-threatening immune-related adverse reactions and must be prescribed, prepared and administered by qualified healthcare professionals. Do not start, stop or modify treatment without consulting your treating oncologist.